Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
36.76
Dollar change
-0.81
Percentage change
-2.16
%
IndexRUT P/E- EPS (ttm)-2.84 Insider Own2.25% Shs Outstand65.91M Perf Week-7.64%
Market Cap2.42B Forward P/E- EPS next Y-2.86 Insider Trans-19.25% Shs Float64.43M Perf Month6.06%
Income-144.88M PEG- EPS next Q-0.59 Inst Own104.51% Short Float10.84% Perf Quarter-4.59%
Sales6.07M P/S399.15 EPS this Y18.76% Inst Trans1.84% Short Ratio10.86 Perf Half Y-7.31%
Book/sh12.72 P/B2.89 EPS next Y-20.61% ROA-24.28% Short Interest6.99M Perf Year-0.84%
Cash/sh12.43 P/C2.96 EPS next 5Y- ROE-25.39% 52W Range22.11 - 53.18 Perf YTD-7.31%
Dividend Est.- P/FCF- EPS past 5Y27.41% ROI-17.27% 52W High-30.88% Beta1.58
Dividend TTM- Quick Ratio31.77 Sales past 5Y30.09% Gross Margin49.65% 52W Low66.26% ATR (14)1.63
Dividend Ex-Date- Current Ratio31.77 EPS Y/Y TTM-12.67% Oper. Margin-2473.30% RSI (14)47.72 Volatility3.78% 4.38%
Employees160 Debt/Eq0.00 Sales Y/Y TTM92.76% Profit Margin-2385.97% Recom1.20 Target Price66.78
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q10.39% Payout- Rel Volume0.75 Prev Close37.57
Sales Surprise-75.28% EPS Surprise19.18% Sales Q/Q-83.87% EarningsMay 06 AMC Avg Volume643.05K Price36.76
SMA20-1.42% SMA50-0.54% SMA2001.74% Trades Volume480,429 Change-2.16%
Date Action Analyst Rating Change Price Target Change
Jun-18-24Initiated Stifel Buy $58
Jun-11-24Initiated Wolfe Research Outperform $51
Dec-20-23Initiated TD Cowen Outperform
Nov-10-23Upgrade Wells Fargo Underweight → Equal Weight $27
Aug-22-23Initiated Wells Fargo Underweight $21
Sep-17-21Initiated Jefferies Buy $66
Sep-10-21Initiated SVB Leerink Outperform $68
Jul-22-21Initiated Guggenheim Buy $66
Feb-21-20Initiated Cantor Fitzgerald Overweight $8
Aug-01-17Resumed H.C. Wainwright Buy $10
Jul-17-24 07:45AM
Jul-16-24 08:01AM
Jun-11-24 07:00PM
Jun-04-24 04:01PM
Jun-02-24 09:01AM
09:55AM Loading…
May-27-24 09:55AM
May-15-24 11:33AM
08:01AM
May-09-24 09:55AM
May-06-24 09:55PM
04:22PM
04:01PM
Apr-17-24 08:01AM
Apr-09-24 09:35AM
Apr-08-24 12:00PM
09:35AM Loading…
09:35AM
Mar-20-24 09:55AM
Mar-08-24 07:00AM
Mar-05-24 10:30AM
10:10AM
Feb-29-24 09:14PM
12:00PM
09:55AM
Feb-28-24 04:01PM
Feb-26-24 04:03PM
12:11PM
08:10AM
07:32AM
07:19AM
07:01AM
02:05PM Loading…
Feb-24-24 02:05PM
Feb-20-24 08:26AM
Feb-06-24 04:01PM
Feb-05-24 08:01AM
Nov-27-23 04:15PM
Nov-17-23 01:08PM
Nov-07-23 11:15PM
04:01PM
Nov-06-23 06:47PM
04:01PM
12:15PM
07:00AM
06:30AM
Nov-05-23 03:00PM
Nov-04-23 05:39AM
Nov-02-23 04:25PM
04:01PM
Sep-26-23 07:01AM
Sep-25-23 08:31AM
Aug-22-23 09:35AM
Aug-08-23 05:30PM
04:21PM
04:01PM
Jul-11-23 08:01AM
Jul-06-23 08:01AM
Jun-10-23 10:45AM
Jun-08-23 04:01PM
Jun-02-23 08:01AM
May-31-23 08:01AM
May-23-23 06:10AM
May-15-23 08:01AM
May-04-23 06:05PM
05:03PM
04:01PM
Apr-18-23 05:58AM
Apr-12-23 08:13AM
Mar-29-23 09:01AM
Mar-02-23 05:40AM
Feb-28-23 04:01PM
Feb-27-23 10:25AM
Feb-26-23 09:00AM
Feb-16-23 04:01PM
Feb-15-23 07:00AM
Feb-03-23 07:01AM
Jan-18-23 02:38PM
Dec-06-22 06:00AM
Dec-02-22 09:31AM
Nov-27-22 09:45AM
Nov-10-22 04:01PM
Nov-09-22 05:25PM
04:01PM
Nov-02-22 10:01AM
Nov-01-22 10:01AM
Aug-08-22 05:25PM
04:01PM
Jul-21-22 08:00AM
Jul-08-22 09:26AM
Jul-06-22 09:55AM
07:20AM
Jul-05-22 03:57PM
Jul-04-22 11:49AM
Jul-01-22 04:11PM
10:11AM
Jun-30-22 06:01PM
Jun-22-22 09:24AM
Jun-21-22 08:00AM
Jun-20-22 10:35AM
Jun-16-22 04:01PM
Jun-06-22 04:05PM
May-19-22 09:23AM
Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Crowley ElizabethSR. VP & CPDOJun 14 '24Option Exercise10.3830,000311,40039,074Jun 18 04:04 PM
Martin Samuel BatesSVP AND CFOJun 14 '24Option Exercise10.1620,169204,99045,297Jun 18 04:05 PM
Crowley ElizabethSR. VP & CPDOJun 14 '24Sale34.8730,0001,045,9629,074Jun 18 04:04 PM
Martin Samuel BatesSVP AND CFOJun 14 '24Sale35.4217,172608,31528,125Jun 18 04:05 PM
Young Diane C.SVP, CHIEF MEDICAL OFFICERJun 11 '24Option Exercise2.7115,00040,65017,115Jun 13 04:05 PM
Crowley ElizabethSR. VP & CPDOJun 07 '24Option Exercise9.7015,000145,47424,074Jun 11 04:02 PM
Young Diane C.SVP, CHIEF MEDICAL OFFICERJun 07 '24Sale35.2645,0001,586,8442,115Jun 11 04:01 PM
Crowley ElizabethSR. VP & CPDOJun 07 '24Sale35.0615,000525,8739,074Jun 11 04:02 PM
Jimenez Freddy A.SVP & GENERAL COUNSELJun 05 '24Option Exercise10.389,54099,02535,464Jun 07 04:05 PM
Wright Richard M.SR. VP & CCOJun 03 '24Option Exercise18.7967,4691,267,54067,677Jun 05 04:05 PM
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRSJun 03 '24Option Exercise10.2564,658662,57571,752Jun 05 04:06 PM
Jimenez Freddy A.SVP & GENERAL COUNSELJun 03 '24Option Exercise10.388,00683,10233,930Jun 05 04:04 PM
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRSJun 03 '24Sale33.6558,3691,964,08813,383Jun 05 04:06 PM
Wright Richard M.SR. VP & CCOJun 03 '24Sale33.7246,8441,579,35320,833Jun 05 04:05 PM
Jimenez Freddy A.SVP & GENERAL COUNSELJun 03 '24Sale33.608,006269,00225,924Jun 05 04:04 PM
Martin Samuel BatesSVP AND CFOMay 30 '24Option Exercise10.3825,000259,50060,128Jun 03 04:05 PM
Crowley ElizabethSR. VP & CPDOMay 30 '24Option Exercise4.0142,945172,39747,671Jun 03 04:04 PM
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRSMay 30 '24Option Exercise3.7533,719126,30145,813Jun 03 04:06 PM
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.May 30 '24Option Exercise5.8020,853120,97922,713Jun 03 04:04 PM
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRSMay 30 '24Sale34.0738,7191,319,1567,094Jun 03 04:06 PM
Crowley ElizabethSR. VP & CPDOMay 30 '24Sale33.6438,5971,298,3849,074Jun 03 04:04 PM
Martin Samuel BatesSVP AND CFOMay 30 '24Sale34.0535,0001,191,77425,128Jun 03 04:05 PM
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.May 30 '24Sale33.7320,853703,3341,860Jun 03 04:04 PM
Jimenez Freddy A.SVP & GENERAL COUNSELFeb 13 '24Option Exercise3.8624,16693,16325,924Feb 15 04:05 PM
Martin Samuel BatesSVP AND CFOJan 02 '24Option Exercise2.7810,75029,88535,128Jan 04 04:05 PM